The selection of study endpoints is one of many risks that a clinical research study can face. An independent review can help avert this by identifying potential issues within clinical trial data early in the study and allowing the study team to monitor, intervene and reduce study risks.
Respiratory disease trials are difficult to initiate, both in terms of patient recruitment and accurately collecting data. Alternative methods are required to improve outcomes and develop new treatments for respiratory diseases.
Without question, advanced cellular and gene therapies require well-defined cold-chain management solutions that reduce risk and include all elements of packaging, data collection and logistics expertise to ensure high-quality, effective treatments reach the point of care, and ultimately, the patient.
Evaluating the use of new tumor measurement tools for studies of molecular-targeted cancer therapies.
Biomedical Systems announces a partnership with Chicago based digital health company Foundry Health.
The new facility replaces the company’s current Moscow depot and increases its size and capabilities--including local sourcing of comparator drugs and secondary packaging and labeling.
UPS announces an expansion of its shipping capabilities to support clinical trials.
Biomedical Systems has opened its new technology and research center in St. Louis, Missouri near the company's global headquarters.
Exco InTouch has announced a partnership with AliveCor in order to make mobile electrocardiogram (ECG) measurements available in clinical research.